{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:31:15Z","timestamp":1762324275824,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["ISF 738\/11"],"award-info":[{"award-number":["ISF 738\/11"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001739","name":"National Institute for Psychobiology in Israel, Hebrew University of Jerusalem","doi-asserted-by":"publisher","award":["NIPI-7-2011-12"],"award-info":[{"award-number":["NIPI-7-2011-12"]}],"id":[{"id":"10.13039\/501100001739","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open University of Israel Foundation"},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","award":["3-13552"],"award-info":[{"award-number":["3-13552"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s12031-018-1078-2","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T05:35:55Z","timestamp":1525757755000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GABAA Receptor Density Is Not Altered by a Novel Herbal Anxiolytic Treatment"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6523-9886","authenticated-orcid":false,"given":"Ravid","family":"Doron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avital","family":"Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf","family":"Handelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roni","family":"Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motty","family":"Franko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafit","family":"Hirshler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alon","family":"Shamir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Or","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Rehavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1017\/S1461145704004808","volume":"8","author":"A Avital","year":"2005","unstructured":"Avital A, Richter-Levin G (2005) Exposure to juvenile stress exacerbates the behavioural consequences of exposure to stress in the adult rat. Int J Neuropsychopharmacol 8:163\u2013173. \n                    https:\/\/doi.org\/10.1017\/S1461145704004808","journal-title":"Int J Neuropsychopharmacol"},{"key":"1078_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0014-2999(86)90352-3","volume":"129","author":"N Avnimelech-Gigus","year":"1986","unstructured":"Avnimelech-Gigus N, Feldon J, Tanne Z, Gavish M (1986) The effects of prenatal chlordiazepoxide administration on avoidance behavior and benzodiazepine receptor density in adult albino rats. Eur J Pharmacol 129:185\u2013188. \n                    https:\/\/doi.org\/10.1016\/0014-2999(86)90352-3","journal-title":"Eur J Pharmacol"},{"key":"1078_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1017\/S003329171200147X","volume":"43","author":"AJ Baxter","year":"2013","unstructured":"Baxter AJ, Scott KM, Vos T, Whiteford HA (2013) Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 43:897\u2013910. \n                    https:\/\/doi.org\/10.1017\/S003329171200147X","journal-title":"Psychol Med"},{"key":"1078_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/0006-8993(93)90375-W","volume":"604","author":"J Benavides","year":"1993","unstructured":"Benavides J, Peny B, Ruano D, Vitorica J, Scatton B (1993) Comparative autoradiographic distribution of central \u03c9 (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 604:240\u2013250. \n                    https:\/\/doi.org\/10.1016\/0006-8993(93)90375-W","journal-title":"Brain Res"},{"key":"1078_CR5","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1176\/appi.ajp.157.7.1120","volume":"157","author":"JD Bremner","year":"2000","unstructured":"Bremner JD, Innis RB, Southwick SM, Staib L, Zoghbi S, Charney DS (2000) Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry 157:1120\u20131126. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.157.7.1120","journal-title":"Am J Psychiatry"},{"key":"1078_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/1471-2296-6-20","volume":"44","author":"N Britten","year":"1994","unstructured":"Britten N (1994) Patients\u2019 ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 44:465\u2013468. \n                    https:\/\/doi.org\/10.1186\/1471-2296-6-20","journal-title":"Br J Gen Pract"},{"key":"1078_CR7","doi-asserted-by":"publisher","unstructured":"Burstein O, Franko M, Gale E, Handelsman A, Barak S, Motsan S, Shamir A, Toledano R, Simhon O, Hirshler Y, Chen G, DoronR (2017) Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression. PLoS One 12. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0188043","DOI":"10.1371\/journal.pone.0188043"},{"key":"1078_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1055\/s-2004-832631","volume":"70","author":"V Butterweck","year":"2004","unstructured":"Butterweck V, Hegger M, Winterhoff H (2004) Flavonoids of St. John\u2019s Wort reduce HPA axis function in the rat. Planta Med 70:1008\u20131011. \n                    https:\/\/doi.org\/10.1055\/s-2004-832631","journal-title":"Planta Med"},{"key":"1078_CR9","doi-asserted-by":"publisher","unstructured":"Carobrez AP, Bertoglio LJ (2005) Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. In: Neuroscience and Biobehavioral Reviews. pp 1193\u20131205. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2005.04.017","DOI":"10.1016\/j.neubiorev.2005.04.017"},{"key":"1078_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","volume":"277","author":"G Chouinard","year":"2004","unstructured":"Chouinard G (2004) Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 277:301\u2013306. \n                    https:\/\/doi.org\/10.1001\/jama.1997.03540280039031","journal-title":"J Clin Psychiatry"},{"key":"1078_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/12207","volume":"2","author":"F Crestani","year":"1999","unstructured":"Crestani F, Lorez M, Baer K, Essrich C, Benke D, Laurent JP, Belzung C, Fritschy JM, L\u00fcscher B, Mohler H (1999) Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 2:833\u2013839. \n                    https:\/\/doi.org\/10.1038\/12207","journal-title":"Nat Neurosci"},{"key":"1078_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.lfs.2012.05.014","volume":"90","author":"R Doron","year":"2012","unstructured":"Doron R, Lotan D, Rak-Rabl A, Raskin-Ramot A, Lavi K, Rehavi M (2012) Anxiolytic effects of a novel herbal treatment in mice models of anxiety. Life Sci 90:995\u20131000. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2012.05.014","journal-title":"Life Sci"},{"key":"1078_CR13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lfs.2013.10.025","volume":"94","author":"R Doron","year":"2014","unstructured":"Doron R, Lotan D, Einat N, Yaffe R, Winer A, Marom I, Meron G, Kately N, Rehavi M (2014a) A novel herbal treatment reduces depressive-like behaviors and increases BDNF levels in the brain of stressed mice. Life Sci 94:151\u2013157. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2013.10.025","journal-title":"Life Sci"},{"key":"1078_CR14","doi-asserted-by":"publisher","first-page":"e91455","DOI":"10.1371\/journal.pone.0091455","volume":"9","author":"R Doron","year":"2014","unstructured":"Doron R, Lotan D, Versano Z, Benatav L, Franko M, Armoza S, Kately N, Rehavi M (2014b) Escitalopram or novel herbal mixture treatments during or following exposure to stress reduce anxiety-like behavior through corticosterone and BDNF modifications. PLoS One 9:e91455. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0091455","journal-title":"PLoS One"},{"key":"1078_CR15","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1001\/jama.286.24.3089","volume":"286","author":"SR Dube","year":"2001","unstructured":"Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH (2001) Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the adverse childhood experiences study. JAMA 286:3089\u20133096. \n                    https:\/\/doi.org\/10.1001\/jama.286.24.3089","journal-title":"JAMA"},{"key":"1078_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.physbeh.2004.01.013","volume":"81","author":"C Ducottet","year":"2004","unstructured":"Ducottet C, Belzung C (2004) Behaviour in the elevated plus-maze predicts coping after subchronic mild stress in mice. Physiol Behav 81:417\u2013426. \n                    https:\/\/doi.org\/10.1016\/j.physbeh.2004.01.013","journal-title":"Physiol Behav"},{"key":"1078_CR17","doi-asserted-by":"publisher","unstructured":"Duval ER, Javanbakht A, Liberzon I (2015) Neural circuits in anxiety and stress disorders: a focused review. Ther Clin Risk Manag. \n                    https:\/\/doi.org\/10.2147\/TCRM.S48528","DOI":"10.2147\/TCRM.S48528"},{"key":"1078_CR18","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3609-06.2007","volume":"27","author":"JC Earnheart","year":"2007","unstructured":"Earnheart JC, Schweizer C, Crestani F, Iwasato T, Itohara S, Mohler H, Luscher B (2007) GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J Neurosci 27:3845\u20133854. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3609-06.2007","journal-title":"J Neurosci"},{"key":"1078_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.janxdis.2012.07.009","volume":"26","author":"FJ Farach","year":"2012","unstructured":"Farach FJ, Pruitt LD, Jun JJ, Jerud AB, Zoellner LA, Roy-Byrne PP (2012) Pharmacological treatment of anxiety disorders: current treatments and future directions. J Anxiety Disord 26:833\u2013843. \n                    https:\/\/doi.org\/10.1016\/j.janxdis.2012.07.009","journal-title":"J Anxiety Disord"},{"key":"1078_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/308074a0","volume":"308","author":"DW Gallager","year":"1984","unstructured":"Gallager DW, Lakoski JM, Gonsalves Rauch SFSL (1984) Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity. Nature 308:74\u201377. \n                    https:\/\/doi.org\/10.1038\/308074a0","journal-title":"Nature"},{"key":"1078_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02244183","volume":"104","author":"WR Galpern","year":"1991","unstructured":"Galpern WR, Lumpkin M, Greenblatt DJ, Shader RI, Miller LG (1991) Chronic benzodiazepine administration. Psychopharmacology 104:225\u2013230","journal-title":"Psychopharmacology"},{"key":"1078_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1001\/archpsyc.65.10.1166","volume":"65","author":"G Hasler","year":"2008","unstructured":"Hasler G, Nugent AC, Carlson PJ, Carson RE, Geraci M, Drevets WC (2008) Altered cerebral \u03b3-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography. Arch Gen Psychiatry 65:1166\u20131175. \n                    https:\/\/doi.org\/10.1001\/archpsyc.65.10.1166","journal-title":"Arch Gen Psychiatry"},{"key":"1078_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2165\/00023210-200923020-00002","volume":"23","author":"MA Katzman","year":"2009","unstructured":"Katzman MA (2009) Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 23:103\u2013120. \n                    https:\/\/doi.org\/10.2165\/00023210-200923020-00002","journal-title":"CNS Drugs"},{"key":"1078_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","volume":"12","author":"J Kaufman","year":"2000","unstructured":"Kaufman J, Charney D (2000) Comorbidity of mood and anxiety disorders. Depress Anxiety 12:69\u201376. \n                    https:\/\/doi.org\/10.1002\/1520-6394(2000)12:1+<69::AID-DA9>3.0.CO;2-K","journal-title":"Depress Anxiety"},{"key":"1078_CR25","doi-asserted-by":"crossref","unstructured":"Kessler RC, Ruscio AM, Shear K, Wittchen H-U (2009) Epidemiology of anxiety disorders. In: Behavioral neurobiology of anxiety and its treatment. Springer, pp 21\u201335","DOI":"10.1007\/7854_2009_9"},{"key":"1078_CR26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1078\/0944-7113-00324","volume":"10","author":"RD Lin","year":"2003","unstructured":"Lin RD, Hou WC, Yen KY, Lee MH (2003) Inhibition of monoamine oxidase B (MAO-B) by Chinese herbal medicines. Phytomedicine 10:650\u2013656. \n                    https:\/\/doi.org\/10.1078\/0944-7113-00324","journal-title":"Phytomedicine"},{"issue":"Suppl 3","key":"1078_CR27","first-page":"21","volume":"64","author":"RB Lydiard","year":"2003","unstructured":"Lydiard RB (2003) The role of GABA in anxiety disorders. J Clin Psychiatry 64(Suppl 3):21\u201327","journal-title":"J Clin Psychiatry"},{"key":"1078_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/10401230209147454","volume":"14","author":"PS Masand","year":"2002","unstructured":"Masand PS, Gupta S (2002) Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 14:175\u2013182. \n                    https:\/\/doi.org\/10.1023\/A:1021141404535","journal-title":"Ann Clin Psychiatry"},{"key":"1078_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-2999(83)90306-0","volume":"96","author":"JH Medina","year":"1983","unstructured":"Medina JH, Novas ML, De Robertis E (1983a) Changes in benzodiazepine receptors by acute stress: different effect of chronic diazepam or Ro 15-1788 treatment. Eur J Pharmacol 96:181\u2013185. \n                    https:\/\/doi.org\/10.1016\/0014-2999(83)90306-0","journal-title":"Eur J Pharmacol"},{"key":"1078_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-2999(83)90223-6","volume":"90","author":"JH Medina","year":"1983","unstructured":"Medina JH, Novas ML, De Robertis E (1983b) Chronic RO 15-1788 treatment increases the number of benzodiazepine receptors in rat cerebral cortex and hippocampus. Eur J Pharmacol 90:125\u2013128. \n                    https:\/\/doi.org\/10.1016\/0014-2999(83)90223-6","journal-title":"Eur J Pharmacol"},{"key":"1078_CR31","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1016\/0006-2952(89)90584-4","volume":"38","author":"LG Miller","year":"1989","unstructured":"Miller LG, Woolverton S, Greenblatt DJ, Lopez F, Roy RB, Shader RI (1989) Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration. Biochem Pharmacol 38:3773\u20133777. \n                    https:\/\/doi.org\/10.1016\/0006-2952(89)90584-4","journal-title":"Biochem Pharmacol"},{"key":"1078_CR32","doi-asserted-by":"publisher","unstructured":"M\u00f6hler H (2012) The GABA system in anxiety and depression and its therapeutic potential. In: Neuropharmacology. pp 42\u201353. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2011.08.040","DOI":"10.1016\/j.neuropharm.2011.08.040"},{"key":"1078_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0006-8993(78)90526-7","volume":"156","author":"H M\u00f6hler","year":"1978","unstructured":"M\u00f6hler H, Okada T, Enna SJ (1978) Benzodiasepine and neurotransmitter receptor bunding in rat brain after chronic administration of diazepam or phenobarbital. Brain Res 156:391\u2013395. \n                    https:\/\/doi.org\/10.1016\/0006-8993(78)90526-7","journal-title":"Brain Res"},{"key":"1078_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1111\/j.1471-4159.1988.tb01137.x","volume":"51","author":"P Montpied","year":"1988","unstructured":"Montpied P, Martin BM, Cottingham SL, Stubblefield BK, Ginns EI, Paul SM (1988) Regional distribution of the GABAA\/benzodiazepine receptor ($\u03b1$ subunit) mRNA in rat brain. J Neurochem 51:1651\u20131654","journal-title":"J Neurochem"},{"key":"1078_CR35","first-page":"133","volume":"37","author":"CB Nemeroff","year":"2003","unstructured":"Nemeroff CB (2003) The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 37:133\u2013146","journal-title":"Psychopharmacol Bull"},{"key":"1078_CR36","doi-asserted-by":"publisher","unstructured":"Nikolaus S, Antke C, Beu M, M\u00fcller H-W (2010) Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders\u2014results from in vivo imaging studies. Rev Neurosci 21. \n                    https:\/\/doi.org\/10.1515\/REVNEURO.2010.21.2.119","DOI":"10.1515\/REVNEURO.2010.21.2.119"},{"key":"1078_CR37","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/NDT.S58841","volume":"11","author":"P Nuss","year":"2015","unstructured":"Nuss P (2015) Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat 11:165\u2013175. \n                    https:\/\/doi.org\/10.2147\/NDT.S58841","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1078_CR38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1192\/bjp.179.5.390","volume":"179","author":"DJ Nutt","year":"2001","unstructured":"Nutt DJ, Malizia AL (2001) New insights into the role of the GABAA-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179:390\u2013396. \n                    https:\/\/doi.org\/10.1192\/bjp.179.5.390","journal-title":"Br J Psychiatry"},{"issue":"Suppl 1","key":"1078_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuroimage.2010.03.037","volume":"65","author":"DJ Nutt","year":"2004","unstructured":"Nutt DJ, Malizia AL (2004) Structural and functional brain changes in posttraumatic stress disorder. J Clin Psychiatry 65(Suppl 1):11\u201317. \n                    https:\/\/doi.org\/10.1016\/j.neuroimage.2010.03.037","journal-title":"J Clin Psychiatry"},{"key":"1078_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0378-8741(00)00255-5","volume":"72","author":"WH Peng","year":"2000","unstructured":"Peng WH, Hsieh MT, Lee YS, Lin YC, Liao J (2000) Anxiolytic effect of seed of Ziziphus jujuba in mouse models of anxiety. J Ethnopharmacol 72:435\u2013441. \n                    https:\/\/doi.org\/10.1016\/S0378-8741(00)00255-5","journal-title":"J Ethnopharmacol"},{"key":"1078_CR41","doi-asserted-by":"publisher","unstructured":"Penza KM, Heim C, Nemeroff CB (2003) Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety. In: Archives of Women\u2019s Mental Health. pp 15\u201322. \n                    https:\/\/doi.org\/10.1007\/s00737-002-0159-x","DOI":"10.1007\/s00737-002-0159-x"},{"key":"1078_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","volume":"71","author":"LN Ravindran","year":"2010","unstructured":"Ravindran LN, Stein MB (2010) The pharmacologic treatment of anxiety disorders: a review of progress. J Clin Psychiatry 71:839\u2013854. \n                    https:\/\/doi.org\/10.4088\/JCP.10r06218blu","journal-title":"J Clin Psychiatry"},{"key":"1078_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/1467-9566.ep11433593","volume":"15","author":"A Rogers","year":"1993","unstructured":"Rogers A, Pilgrim D (1993) Service users\u2019 views of psychiatric treatments. Sociol Health Illn 15:612\u2013631. \n                    https:\/\/doi.org\/10.1111\/1467-9566.ep11433593","journal-title":"Sociol Health Illn"},{"key":"1078_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.genhosppsych.2007.12.006","volume":"30","author":"PP Roy-Byrne","year":"2008","unstructured":"Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB (2008) Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 30:208\u2013225. \n                    https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.12.006","journal-title":"Gen Hosp Psychiatry"},{"key":"1078_CR45","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","volume":"26","author":"R Sankar","year":"2012","unstructured":"Sankar R (2012) GABAA receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs 26:229\u2013244","journal-title":"CNS Drugs"},{"key":"1078_CR46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-013-0044-3","volume":"27","author":"J Sarris","year":"2013","unstructured":"Sarris J, McIntyre E, Camfield DA (2013) Plant-based medicines for anxiety disorders, part 1: a review of preclinical studies. CNS Drugs 27:207\u2013219. \n                    https:\/\/doi.org\/10.1007\/s40263-013-0044-3","journal-title":"CNS Drugs"},{"key":"1078_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/j.2051-5545.2010.tb00296.x","volume":"9","author":"N Sartorius","year":"2010","unstructured":"Sartorius N, Gaebel W, Cleveland HR, Stuart H, Akiyama T, Arboleda-Fl\u00f3rez J, Baumann AE, Gureje O, Jorge MR, Kastrup M, Suzuki Y, Tasman A (2010) WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry 9:131\u2013144. \n                    https:\/\/doi.org\/10.1002\/j.2051-5545.2010.tb00296.x","journal-title":"World Psychiatry"},{"key":"1078_CR48","volume-title":"Chinese herbal medicine: formulas and strategies","author":"V Scheid","year":"2009","unstructured":"Scheid V, Bensky D, Ellis A, Barolet R (2009) Chinese herbal medicine: formulas and strategies, 2nd edn. Eastland Press, Seattle","edition":"2"},{"key":"1078_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/camh.12051","volume":"20","author":"A Schimmenti","year":"2015","unstructured":"Schimmenti A, Bifulco A (2015) Linking lack of care in childhood to anxiety disorders in emerging adulthood: the role of attachment styles. Child Adolesc Ment Health 20:41\u201348. \n                    https:\/\/doi.org\/10.1111\/camh.12051","journal-title":"Child Adolesc Ment Health"},{"key":"1078_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0006-8993(90)91173-E","volume":"512","author":"A Shekhar","year":"1990","unstructured":"Shekhar A, Hingtgen JN, DiMicco JA (1990) GABA receptors in the posterior hypothalamus regulate experimental anxiety in rats. Brain Res 512:81\u201388. \n                    https:\/\/doi.org\/10.1016\/0006-8993(90)91173-E","journal-title":"Brain Res"},{"key":"1078_CR51","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.4088\/JCP.08m04485blu","volume":"70","author":"NM Simon","year":"2009","unstructured":"Simon NM, Otto MW, Worthington JJ, Hoge EA, Thompson EH, LeBeau RT, Moshier SJ, Zalta AK, Pollack MH (2009) Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial. J Clin Psychiatry 70:1563\u20131570. \n                    https:\/\/doi.org\/10.4088\/JCP.08m04485blu","journal-title":"J Clin Psychiatry"},{"key":"1078_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.phymed.2011.10.009","volume":"19","author":"J Singhuber","year":"2012","unstructured":"Singhuber J, Baburin I, K\u00e4hlig H, Urban E, Kopp B, Hering S (2012) GABAA receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety. Phytomedicine 19:334\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.phymed.2011.10.009","journal-title":"Phytomedicine"},{"key":"1078_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.neuropharm.2012.03.001","volume":"63","author":"KS Smith","year":"2012","unstructured":"Smith KS, Engin E, Meloni EG, Rudolph U (2012) Benzodiazepine-induced anxiolysis and reduction of conditioned fear are mediated by distinct GABAAreceptor subtypes in mice. Neuropharmacology 63:250\u2013258. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2012.03.001","journal-title":"Neuropharmacology"},{"key":"1078_CR54","doi-asserted-by":"publisher","unstructured":"Tan KR, Rudolph U, Lu C (2011) Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Cell Press, pp 1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.tins.2011.01.004","DOI":"10.1016\/j.tins.2011.01.004"},{"key":"1078_CR55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/14656566.7.4.429","volume":"7","author":"ME Thase","year":"2006","unstructured":"Thase ME (2006) Managing depressive and anxiety disorders with escitalopram. Expert Opin Pharmacother 7:429\u2013440. \n                    https:\/\/doi.org\/10.1517\/14656566.7.4.429","journal-title":"Expert Opin Pharmacother"},{"key":"1078_CR56","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1177\/0269881113492027","volume":"27","author":"E Whiskey","year":"2013","unstructured":"Whiskey E, Taylor D (2013) A review of the adverse effects and safety of noradrenergic antidepressants. J Psychopharmacol 27:732\u2013739. \n                    https:\/\/doi.org\/10.1177\/0269881113492027","journal-title":"J Psychopharmacol"},{"key":"1078_CR57","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/S0006-291X(88)81036-2","volume":"157","author":"J Wildmann","year":"1988","unstructured":"Wildmann J (1988) Increase of natural benzodiazepines in wheat and potato during germination. Biochem Biophys Res Commun 157:1436\u20131443. \n                    https:\/\/doi.org\/10.1016\/S0006-291X(88)81036-2","journal-title":"Biochem Biophys Res Commun"},{"key":"1078_CR58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0149-7634(05)80194-0","volume":"16","author":"P Willner","year":"1992","unstructured":"Willner P, Muscat R, Papp M (1992) Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525\u2013534. \n                    https:\/\/doi.org\/10.1016\/S0149-7634(05)80194-0","journal-title":"Neurosci Biobehav Rev"},{"key":"1078_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jep.2010.01.034","volume":"128","author":"Z You","year":"2010","unstructured":"You Z, Xia Q, Liang F, Tang Y, Xu C, Huang J, Zhao L, Zhang W, He J (2010) Effects on the expression of GABAA receptor subunits by jujuboside A treatment in rat hippocampal neurons. J Ethnopharmacol 128:419\u2013423. \n                    https:\/\/doi.org\/10.1016\/j.jep.2010.01.034","journal-title":"J Ethnopharmacol"},{"key":"1078_CR60","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/0306-4522(88)90036-X","volume":"25","author":"J Zezula","year":"1988","unstructured":"Zezula J, Cort\u00e9s R, Probst A, Palacios JM (1988) Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience 25:771\u2013795. \n                    https:\/\/doi.org\/10.1016\/0306-4522(88)90036-X","journal-title":"Neuroscience"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-018-1078-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-018-1078-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T16:44:08Z","timestamp":1557420248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-018-1078-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1007\/s12031-018-1078-2","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"type":"print","value":"0895-8696"},{"type":"electronic","value":"1559-1166"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"28 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were approved by the Academic College Tel Aviv Yaffo committee for animal care and use. Methods were carried out in accordance with the NIH guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}